BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.700
+0.030 (1.80%)
At close: Aug 13, 2025, 4:00 PM
1.720
+0.020 (1.18%)
Pre-market: Aug 14, 2025, 9:10 AM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $13.35 million as of August 14, 2025. Its market cap has decreased by -46.59% in one year.
Market Cap
13.35M
Enterprise Value
-9.43M
1-Year Change
-46.59%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $13.35M, a decrease of -74.32%. That is a compound annual growth rate of -24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 3.20M | -90.99% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |